Eduardo M. Sotomayor
Affiliations: | Biology (Cell Biology, Microbiology, Molecular Biology) | University of South Florida, Tampa, FL, United States |
Area:
Cell Biology, Immunology, Molecular BiologyGoogle:
"Eduardo Sotomayor"Children
Sign in to add trainee| Ildefonso Vicente-Suarez | grad student | 2007 | University of South Florida |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vidal-Vanaclocha F, Crende O, García de Durango C, et al. (2020) Liver Prometastatic Reaction: Stimulating Factors and Responsive Cancer Phenotypes. Seminars in Cancer Biology |
| Banik D, Noonepalle S, Hadley M, et al. (2020) HDAC6 plays a non-canonical role in the regulation of anti-tumor immune responses, dissemination, and invasiveness of breast cancer. Cancer Research |
| Beltrán BE, Villela L, Torres MA, et al. (2020) A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL). Clinical Lymphoma, Myeloma & Leukemia |
| Rao R, Nalluri S, Fiskus W, et al. (2020) Editor's Note: Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-mediated Potentiation of Bortezomib-induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 26: 1531 |
| Yue L, Sharma V, Horvat NP, et al. (2019) HDAC11 Deficiency or Inhibition Disrupts Oncogene-Induced Stress Hematopoiesis in Myeloproliferative Neoplasms. Blood |
| Beltran BE, Paredes S, Castro D, et al. (2019) High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy. Clinical Lymphoma, Myeloma & Leukemia |
| Li W, Gupta SK, Han W, et al. (2019) Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors. Journal of Hematology & Oncology. 12: 73 |
| Zhao X, Ren Y, Lawlor M, et al. (2019) BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models. Cancer Cell. 35: 752-766.e9 |
| Kahl BS, Dreyling M, Gordon LI, et al. (2019) Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop. Leukemia & Lymphoma. 1-13 |
| Cheng F, Yan D, Chen J, et al. (2019) Cold Plasma with Immunomodulatory Properties Has Significant Anti-Lymphoma Activities in Vitro and In Vivo Blood. 134: 5307-5307 |